Newsroom of

Synbio Technologies

United States

With the breakthroughs in synthetic biology and system biology, de novo synthesized DNA and RNA molecules or variant libraries are widely used in pharmaceutical, agriculture, biofuel and biological/chemical production. As our understanding of DNA sequences (Genotype) and biological functions (Phenotype) increases, the ability to design and synthesize (Synotype) genes, genomes, pathways, and organisms by using synthetic biology techniques is also improving quickly. Synbio Tech. has created the comprehensive Synotype platforms for biological researchers that dedicate to integrating the cutting edge synthetic biology techniques and bio-informatic tools into an advanced biological innovation platform.

Synbio Technologies’ Synotype platform was conceived, designed and implemented with synthetic biology technology to produce:
1. A novel approach to deepen our knowledge on genotying (reading by writing);
2. A simple approach to characterize phenotyping (understanding by writing);
3. A quick approach to study the correlations of genotyping and phenotyping (linking by writing);
4. A cost effective approach to design and produce the novel sequence and subsequent function traits (creating by writing).
In addition, Synbio Tech. is building up the first integrated GPS (Genotype, Phenotype and Synotype) system aimed to a quick and easy translation or reverse translation between “Genotype” and “Phenotype” by using our proprietary “Synotype” platform.

sgRNA Libraries and Synbio Technologies

sgRNA Libraries Authored by Sybio TechnologiesSynthetic biology has one main goal: retooling and repurposing biological systems for new and novel applications.  One of the premier examples of this revamping of biological systems is the CRISPR-Cas9 defense mechanism.  Originally found in…

Fusion Antibodies Ltd (UK) and Synbio Technologies Co. Ltd announced a partnership

Fusion Antibodies Ltd (UK) and Synbio Technologies Co. Ltd (China/USA) are excited to announce a commercial partnership to support biologic drug development in China.1st June 2017 – Fusion Antibodies Ltd (Belfast, UK) and Synbio Technologies Co Ltd (China/USA), today announce…

Synbio Tech. Announced the Establishment of Cooperative Relations with ALSTEM

Synbio Technologies Announced the Establishment of Cooperative Relations with ALSTEMSynbio Technologies, a leading international synthetic biology service company, recently announced a new partnership with ALSTEM, LLC, a US biotech company, with the aim of developing various human CRISPR-Cas9 sgRNA libraries.…

Synbio Technologies to attend PEGS 2017

Visit our booth, # 112, to learn more about Synbio Technologies' advanced "GPS" (Genotype-Phenotype-Synotype) platforms and comprehensive biological solutions. Our scientific capabilities encompass areas such as: DNA engineering, DNA synthesis, genome synthesis, pathway synthesis, synthetic biology, pharmacogenomics, microbiology, translational biology…

Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers

Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers

Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA Synthesis, today announced that it signed a non-exclusive agreement with Synbio Technologies. The companies will partner their respective capabilities to provide customers with access to long-length genes up…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login